Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of colesevelam on postprandial glucose after Roux-en-Y gastric bypass and cholecystectomy
2021-000667-74Phase 4Active
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Oct 2021
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of colesevelam in postprandial hypoglycemia and post-bariatric hypoglycemia (PBH) (2 arms), sponsored by Medisch Centrum Leeuwarden. Primary endpoint: Glucose nadir during mixed meal test. Started Oct 2021; status: active.
02
Drugs
colesevelam
03
Conditions
postprandial hypoglycemiapost-bariatric hypoglycemia (PBH)
Beyond the preview
Go deeper on 2021-000667-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000667-74.